Shanti Balasubramanian, MD
NPI 1609262237 · Pulmonary Disease Physician · Baltimore, MD
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Shanti Balasubramanian, MD is a Pulmonary Disease Physician provider in Baltimore, MD (NPI 1609262237).
Provider details
- NPI number
- 1609262237
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- D85412 (MD)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
11 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
415 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Critical Care, First 30-74 Minutes99291 | 123 | $217 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 80 | $79 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 40 | $17 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 36 | $188 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 34 | $121 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 44 | 16 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 31 | — |
| Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol | 16 | — |
| Fluticasone Propionate | 12 | — |
| Prednisone | 12 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$23 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 300 Hospital Dr Ste 119Glen Burnie, MD 21061-5706Phone: (410) 553-8240
Registry dates
- Enumerated
- 2015-04-10
- Last updated
- 2023-06-29
- Certified
- 2023-06-29
Frequently asked questions
- What is Shanti Balasubramanian's NPI number?
- Shanti Balasubramanian's National Provider Identifier (NPI) is 1609262237, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Shanti Balasubramanian's specialty?
- Shanti Balasubramanian is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
- Where is Shanti Balasubramanian located?
- Shanti Balasubramanian's practice location on file with NPPES is 22 S Greene St, Baltimore, MD 21201-1544.
- What is Shanti Balasubramanian's phone number?
- The practice phone number listed in the NPPES registry for Shanti Balasubramanian is (410) 328-6110.
- Does Shanti Balasubramanian accept Medicare?
- Shanti Balasubramanian is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Shanti Balasubramanian's NPI active?
- Yes — Shanti Balasubramanian's NPI (1609262237) is active in the NPPES registry as of the last update on 2023-06-29.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.